Search Results 921-930 of 39042 for Two-phase

  1. A Study to Evaluate Fisetin to Alleviate Dysfunction and Inflammation in COVID-19 Subjects - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. A Study to Evaluate the Safety and Effectiveness of AB928-Based Treatment Combinations to Treat Patients with Metastatic Colorectal Cancer - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  3. A Study Comparing Gemcitabine with or without AZD 1775 in Treating Patients with Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  4. A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. A Study of Gemcitabine-Cisplatin Chemotherapy plus Necitumumab in the First-Line Treatment of Patients with Lung Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  6. Mild cognitive impairment - Diagnosis and treatment - Mayo Clinic

    Learn more about this stage ... This medicine is given as an IV infusion every two weeks. ... Your healthcare team monitors your blood pressure and can recommend ...

  7. A Study To Assess The Effectiveness And Safety Of AF-219 For Subjects With A Treatment Resistant Chronic Cough - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  8. Panobinostat in Treating Patients with Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Study phase. 2/3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  10. Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation - Mayo Clinic

    Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation · Overview · Participation eligibility · Participating Mayo ...